Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 151

    1.

    Pegylated interferon-alpha2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B.

    ter Borg MJ, Janssen HL.

    Ann Intern Med. 2005 Sep 6;143(5):391; author reply 391-2. No abstract available. PMID: 16144900 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Pegylated interferon Alfa-2b monotherapy and pegylated interferon Alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B.

    Kaymakoglu S, Oguz D, Gur G, Gurel S, Tankurt E, Ersöz G, Ozenirler S, Kalayci C, Poturoglu S, Cakaloglu Y, Okten A.

    Antimicrob Agents Chemother. 2007 Aug;51(8):3020-2. Epub 2007 May 21.PMID: 17517832 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Treatment of hepatitis B with interferon and combination therapy.

    Cooksley WG.

    Clin Liver Dis. 2004 May;8(2):353-70. Review.PMID: 15481344 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B.

    Vassiliadis T, Tziomalos K, Patsiaoura K, Zagris T, Giouleme O, Soufleris K, Grammatikos N, Theodoropoulos K, Mpoumponaris A, Dona K, Zezos P, Nikolaidis N, Orfanou-Koumerkeridou E, Balaska A, Eugenidis N.

    J Gastroenterol Hepatol. 2007 Oct;22(10):1582-8. Epub 2007 Aug 7.PMID: 17683500 [PubMed - indexed for MEDLINE]Related articles

    5.

    Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.

    ter Borg MJ, Hansen BE, Herrmann E, Zeuzem S, Cakaloglu Y, Karayalcin S, Flisiak R, van' t Veen A, de Man RA, Schalm SW, Janssen HL, Haagmans BL; HBV 99-01 Study Group.

    Antivir Ther. 2007;12(8):1285-94.PMID: 18240868 [PubMed - indexed for MEDLINE]Related articles

    6.

    Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.

    Flink HJ, Buster EH, Merican I, Nevens F, Kitis G, Cianciara J, de Vries RA, Hansen BE, Schalm SW, Janssen HL.

    Gut. 2007 Oct;56(10):1485-6. No abstract available. PMID: 17872587 [PubMed - indexed for MEDLINE]Related articles

    7.

    A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B.

    Manesis EK, Papatheodoridis GV, Hadziyannis SJ.

    Aliment Pharmacol Ther. 2006 Jan 1;23(1):99-106.PMID: 16393286 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.

    van Zonneveld M, Zondervan PE, Cakaloglu Y, Simon C, Akarca US, So TM, Flink HJ, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study Group.

    Liver Int. 2006 May;26(4):399-405.PMID: 16629642 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.

    Leemans WF, Flink HJ, Janssen HL, Niesters HG, Schalm SW, de Man RA.

    J Hepatol. 2006 Mar;44(3):507-11. Epub 2006 Jan 19.PMID: 16457904 [PubMed - indexed for MEDLINE]Related articles

    10.

    Summaries for patients. Combination therapy for chronic hepatitis B.

    [No authors listed]

    Ann Intern Med. 2005 Feb 15;142(4):I30. No abstract available. PMID: 15710953 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.

    Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL.

    Gastroenterology. 2008 Aug;135(2):459-67. Epub 2008 May 15.PMID: 18585385 [PubMed - indexed for MEDLINE]Related articles

    12.

    Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine.

    Flink HJ, Hansen BE, Heathcote EJ, Feinman SV, Simsek H, Karayalcin S, Mach T, Leemans WF, de Man RA, Verhey E, Schalm SW, Janssen HL; HBV 99-01 Study Group.

    Am J Gastroenterol. 2006 Nov;101(11):2523-9. Epub 2006 Oct 4.PMID: 17029610 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B]

    Vilar Gómez E, Grá Oramas B, Arús Soler E, Ruenes Domech C, Dávila González Y.

    Gastroenterol Hepatol. 2006 Nov;29(9):534-41. Spanish. PMID: 17129547 [PubMed - indexed for MEDLINE]Related articles

    14.

    Chronic Hepatitis B and C--current treatment and future therapeutic prospects.

    Müller C.

    Wien Med Wochenschr. 2006 Jul;156(13-14):391-6. Review.PMID: 16937041 [PubMed - indexed for MEDLINE]Related articles

    15.

    Summaries for patients. Antiviral regimens for chronic hepatitis B virus infection.

    [No authors listed]

    Ann Intern Med. 2005 May 17;142(10):I39. No abstract available. PMID: 15897528 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Antiviral treatment of HBeAg positive chronic hepatitis B]

    Wang GQ.

    Zhonghua Gan Zang Bing Za Zhi. 2005 Jul;13(7):540. Chinese. No abstract available. PMID: 16042897 [PubMed - indexed for MEDLINE]Related articles

    17.

    Interferon therapy in hepatitis B e antigen-negative chronic hepatitis B.

    Colli A, Massironi S, Anreoletti M.

    Hepatology. 2003 Sep;38(3):779-80; author reply 780. No abstract available. PMID: 12939609 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype.

    Flink HJ, van Zonneveld M, Hansen BE, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study Group.

    Am J Gastroenterol. 2006 Feb;101(2):297-303.PMID: 16454834 [PubMed - indexed for MEDLINE]Related articles

    19.

    Interferon therapy for chronic hepatitis B.

    Asselah T, Lada O, Moucari R, Martinot M, Boyer N, Marcellin P.

    Clin Liver Dis. 2007 Nov;11(4):839-49, viii. Review.PMID: 17981231 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Pharmacological agents for the treatment of chronic hepatitis B]

    Sánchez-Tapias JM.

    Gastroenterol Hepatol. 2008 Mar;31(3):120-8. Review. Spanish. No abstract available. PMID: 18341843 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data